Stieven Capital Advisors LP Lowered Svb Finl Group (SIVB) Stake; Stellar Biotechnologies (SBOT) Sellers Decreased By 16% Their Shorts

June 23, 2017 - By Ellis Scott

Stellar Biotechnologies Incorporated (NASDAQ:SBOT) had a decrease of 16% in short interest. SBOT’s SI was 25,200 shares in June as released by FINRA. Its down 16% from 30,000 shares previously. With 25,800 avg volume, 1 days are for Stellar Biotechnologies Incorporated (NASDAQ:SBOT)’s short sellers to cover SBOT’s short positions. The SI to Stellar Biotechnologies Incorporated’s float is 0.33%. The stock increased 11.61% or $0.13 on June 22, reaching $1.25. About shares traded. Stellar Biotechnologies Inc (NASDAQ:SBOT) has declined 60.19% since June 23, 2016 and is downtrending. It has underperformed by 76.89% the S&P500.

Stieven Capital Advisors Lp decreased Svb Finl Group (SIVB) stake by 18.25% reported in 2016Q4 SEC filing. Stieven Capital Advisors Lp sold 22,700 shares as Svb Finl Group (SIVB)’s stock declined 4.82%. The Stieven Capital Advisors Lp holds 101,700 shares with $17.46M value, down from 124,400 last quarter. Svb Finl Group now has $8.98 billion valuation. The stock rose 0.43% or $0.75 reaching $175. About 100 shares traded. SVB Financial Group (NASDAQ:SIVB) has risen 74.61% since June 23, 2016 and is uptrending. It has outperformed by 57.91% the S&P500.

Among 11 analysts covering SVB Financial Group (NASDAQ:SIVB), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. SVB Financial Group had 21 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of SVB Financial Group (NASDAQ:SIVB) has “Overweight” rating given on Wednesday, November 11 by Morgan Stanley. The rating was maintained by RBC Capital Markets on Thursday, November 10 with “Outperform”. As per Friday, January 22, the company rating was upgraded by Piper Jaffray. Piper Jaffray initiated the stock with “Neutral” rating in Tuesday, October 13 report. The firm has “Buy” rating by DA Davidson given on Friday, August 28. Wood maintained it with “Outperform” rating and $131 target in Friday, May 27 report. The rating was downgraded by Barclays Capital on Tuesday, November 1 to “Equal Weight”. Zacks upgraded SVB Financial Group (NASDAQ:SIVB) rating on Monday, August 31. Zacks has “Hold” rating and $140 target. The rating was initiated by JMP Securities with “Mkt Outperform” on Friday, September 16. The firm has “Overweight” rating given on Friday, October 9 by Barclays Capital.

Since January 31, 2017, it had 0 buys, and 11 sales for $14.77 million activity. Descheneaux Michael sold $2.25 million worth of stock. Shares for $5.72M were sold by BECKER GREGORY W. The insider BENHAMOU ERIC sold 2,000 shares worth $393,835. Wallace Bruce sold $1.60M worth of SVB Financial Group (NASDAQ:SIVB) on Monday, May 15. Edmonds-Waters Christopher sold $1.03M worth of SVB Financial Group (NASDAQ:SIVB) on Monday, February 13. 2,600 SVB Financial Group (NASDAQ:SIVB) shares with value of $449,912 were sold by Cadieux Marc C. 2,000 SVB Financial Group (NASDAQ:SIVB) shares with value of $385,922 were sold by STAGLIN GAREN K.

Analysts await SVB Financial Group (NASDAQ:SIVB) to report earnings on July, 20. They expect $2.07 earnings per share, up 16.29% or $0.29 from last year’s $1.78 per share. SIVB’s profit will be $106.22M for 21.14 P/E if the $2.07 EPS becomes a reality. After $1.91 actual earnings per share reported by SVB Financial Group for the previous quarter, Wall Street now forecasts 8.38% EPS growth.